Find relevant information about suPAR news the most groundbreaking studies, case studies, and stories of suPAR success and application.

Female researcher

1000 papers on suPAR on Pubmed

2024-04-04T08:08:07+00:00March 26th, 2024|

1000 papers on suPAR on Pubmed Since uPAR and suPAR was discovered by Danish scientists in the 1990ties, the insight into the functions and clinical significance has exploded. Today, suPAR is understood as the biomarker of chronic inflammation, and [...]

Scientists

Most interesting suPAR studies of 2023

2024-04-04T08:07:44+00:00December 8th, 2023|

2023 yielded many interesting and important studies about suPAR, here is a recap of the most impactful ones An increasing number of suPAR studies highlights its growing importance in healthcare and proves suPAR's versatility and [...]

suPAR can predict disease aggressiveness in renal cell carcinoma

2024-02-08T13:44:56+00:00October 25th, 2023|

suPARnostic®: an advanced predictive tool for detecting recurrence in renal cell carcinoma Background: Plasma soluble urokinase-type Plasminogen Activator Receptor (suPAR) predicts disease aggressiveness in renal cell carcinoma (ccRCC), but its prognostic accuracy has not been [...]

1000+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of four products:

Quick Triage
TurbiLatex
ELISA
POC+

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

POC+

Point-of-care finger prick

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates